What is targeted drug delivery?
There is a big difference between targeted drugs and ordinary drugs. They can neither be taken blindly by themselves, nor can they ignore their suitability.
There is a big difference between targeted drugs and ordinary drugs. They can neither be taken blindly by themselves, nor can they ignore their suitability.
On August 11, aTyr Pharma announced that the FDA has granted Fast Track designation to Efzofitimod (ATYR1923) for the treatment of pulmonary sarcoidosis. This year,
After Daiichi Sankyo detonated the market, ADC instantly became Jerusalem in the hearts of pharmaceutical companies, and pilgrims came in droves. Since the beginning of
On August 10, Insilicon, a clinical-stage drug development company driven by end-to-end artificial intelligence, announced today that it has received a D2 round of financing.
On August 10, Merck and Cerevance announced that they have reached a strategic cooperation agreement to use Cerevance’s proprietary NETSseq transcriptomic technology platform to discover
£415 million! Sartorius acquires recombinant albumin company Albumedix On August 8, the German life sciences group Sartorius announced that through its French-listed subsidiary Sartorius Stedim
BioNTech’s performance fell more than expected after four consecutive quarters of revenue of more than 5 billion euros ($5.1 billion) as demand for the new
There is no accident, let alone fluke, in the research and development of innovative drugs. Even if a star product has proven itself in many
Monkeypox, a smallpox-like virus, is causing global alarm. On July 23, the World Health Organization (WHO) declared monkeypox a global public health emergency (PHEIC). Over
Pfizer has been looking for assets in the biopharmaceutical space to expand its pipeline thanks to the big money it has made from COVID-19. Now,
On August 5, Merck announced that its novel non-nucleoside cytomegalovirus (CMV) inhibitor, Premin® (Litemovir Tablets), was officially launched in China for patients undergoing allogeneic hematopoietic
The distribution of passively targeted microparticles in vivo after intravenous injection first depends on the particle size. Nanocapsules or nanospheres smaller than 100 nm can